Navigation Links
New research examining essential drugs, emerging botanicals supported by USP Awards
Date:10/20/2009

Rockville, Md., October 20, 2009 New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program. USP fellowships are awarded to graduate students enrolled in chemistry, pharmacy, or other health care/scientific doctoral or post-doctoral programs to support research related to quality standards for medicines, dietary supplements and food ingredients.

USP's six fellowship recipients for 2009� are:

  • Paul Gavaza, The University of Texas at Austin, College of Pharmacy

    Area of Research Using the theory of planned behavior to predict Texas pharmacists' intention to report adverse drug events (ADEs). ADEs are unintended, undesirable and harmful events that are associated with the use of a drug. Some ADEs are the result of errors caused by medical staff, and most are preventable. In what is understood to be the first research of U.S. pharmacists' attitudes or willingness to report ADEs, this research will identify pharmacists' beliefs concerning reporting; identify critical factors that influence attitudes and willingness to report ADEs; explore the utility of the theory of planned behavior models in predicting intentions to report ADEs; and examine the relationship between demographic and practice characteristics and the theory of planned behavior model constructs.

  • Tanja Gdecke, University of Illinois, Department of Medicinal Chemistry and Pharmacognosy

    Area of Research Method development for identity and quality control of an Angelica sinensis extract by Nuclear Magnetic Resonance (NMR). Quality control of botanical dietary supplements that contain single or mixed herbs or herbal extracts presents considerable challenges. This research will focus on developing an innovative analytical methodology for the quality control of herbal materials and
    '/>"/>


  • Contact: Francine Pierson
    fp@usp.org
    301-816-8588
    US Pharmacopeia
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. Research shows skeleton to be endocrine organ
    2. Newly created cancer stem cells could aid breast cancer research
    3. Dominant cholesterol-metabolism ideas challenged by new research
    4. Researchers identify proteins involved in new neurodegenerative syndrome
    5. Texas researchers and educators head for Antarctica
    6. MGH researchers describe new way to identify, evolve novel enzymes
    7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
    8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
    9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
    10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
    11. Story ideas from the Journal of Lipid Research
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/22/2014)... Institute of Standards and Technology (NIST), working with ... technique for analyzing biological cells and tissues based ... technique is an advanced form of the widely ... signals that are 10,000 times stronger than obtained ... than obtained from comparable "coherent Raman" instruments, and ...
    (Date:7/22/2014)... commercial diet programs and pills, the Weight Watchers program ... the money. The Jenny Craig regimen generated the greatest ... tested, according to researchers at Duke-National University of Singapore ... the June issue of the journal Obesity , ... per dollar spent as insurance carriers consider coverage for ...
    (Date:7/22/2014)... Nancy Buccola, MSN, APRN, PMHCNS-BC, CNE, Assistant Professor ... New Orleans School of Nursing, contributed samples used ... material associated with schizophrenia and also suggesting a ... The study, Biological insights from 108 schizophrenia-associated genetic ... Nature , available at http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13595.html., ...
    Breaking Biology News(10 mins):Enhanced NIST instrument enables high-speed chemical imaging of tissues 2Enhanced NIST instrument enables high-speed chemical imaging of tissues 3Study compares cost-effectiveness of weight-loss programs and drugs 2Study compares cost-effectiveness of weight-loss programs and drugs 3LSUHSC contributes to work identifying new DNA regions associated with schizophrenia 2
    ... of an embryonic stem cell, which has the potential to ... complex interaction of genes, proteins that bind DNA, and molecules ... paper, biologists from MIT and the University of California at ... of stem cells into mature heart cells. The study, the ...
    ... ultrasound waves, MIT engineers have found a way to ... drug delivery more efficient. This technology could pave the ... to the researchers. "This could be used for ... systemic drugs and proteins such as insulin, as ...
    ... Alps that are not native to that region? Which ... How big a threat will they become to local ... today by the European Commission,s in-house science service, the ... answering these and other questions related to 16 000 ...
    Cached Biology News:Probing matters of the heart 2Probing matters of the heart 3Getting (drugs) under your skin 2Getting (drugs) under your skin 3Environment: Pooling information to combat the threat of alien species in Europe 2Environment: Pooling information to combat the threat of alien species in Europe 3
    (Date:7/22/2014)... water with ultrasound and they,ll spin around their long ... knows exactly. But researchers at the National Institute of ... fast. At up to 150,000 revolutions per minute, these ... submerged in liquid ever reported. , The discovery of ... they could be used not only for moving around ...
    (Date:7/22/2014)... CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer ... cosmetics, and other markets, announced today that it has ... qualified private investors led by Novit L.P., an investment ... transaction involved the signing of a Securities Purchase Agreement ... Stock at a price per share of $1.00, resulting ...
    (Date:7/22/2014)... (PRWEB) July 22, 2014 Two new ... Board of Directors at its annual Shareholders Meeting on ... Information Officer of The PFM Group, and Stephen T. ... Center also announced the election of Michael A. DiPiano, ... Vice Chair and Richard P. Jaffe, Esq., of Duane ...
    (Date:7/22/2014)... Massachusetts e SHENZHEN , ... Co., LTD, (BGI Tech), una filiale di BGI, la ... lancio mondiale di un nuovo servizio di sequenziamento dell,intero ... di Complete Genomics. Complete Genomics, molto ... tecnologie di sequenziamento proprietarie con il 99.999% di precisione ...
    Breaking Biology Technology:NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2
    ... MOUNTAIN VIEW, Calif., Feb. 25 Alexza,Pharmaceuticals, ... that it has initiated,its first Phase 3 ... an inhalation product candidate being developed for ... schizophrenia or bipolar disorder. Alexza,believes the novel, ...
    ... t2cure, a clinical,stage biopharmaceutical company developing novel regenerative ... it has appointed,Dr. Petra Rueck Head of Clinical ... join our company", said Manfred Ruediger,CEO of t2cure. ... be of critical importance to t2cure as we ...
    ... SAN DIEGO, Feb. 25 Speid & Associates, ... is hosting,a six session Webinar series on diabetes ... and April. Speakers will include former Food and,Drug ... Lipicky, as,well as a distinguished list of other ...
    Cached Biology Technology:Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations 2The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics 2
    ... T Squareds patented high efficiency dynamic valve ... With the most compact, lightweight package in ... use in portable air and gas applications., ... high efficiency. , Includes DC Motor. ...
    ...
    Alkaline Phosphatase (E. coli C75), 100 units. Removes 5'-phosphates from DNA. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Alkaline Phosphatases....
    ... CyScribe First-Strand cDNA Labeling System - ... 50 reactions. For the generation and ... reagents are packaged together for complete ... protocols can be used for performing ...
    Biology Products: